These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 37668416)

  • 1. Upregulation of SOX9 promotes the self-renewal and tumorigenicity of cervical cancer through activating the Wnt/β-catenin signaling pathway.
    Feng Q; Cui N; Li S; Cao J; Chen Q; Wang H
    FASEB J; 2023 Oct; 37(10):e23174. PubMed ID: 37668416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LGR6 activates the Wnt/β-catenin signaling pathway and forms a β-catenin/TCF7L2/LGR6 feedback loop in LGR6
    Feng Q; Li S; Ma HM; Yang WT; Zheng PS
    Oncogene; 2021 Oct; 40(42):6103-6114. PubMed ID: 34489551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRIM29 overexpression is associated with poor prognosis and promotes tumor progression by activating Wnt/β-catenin pathway in cervical cancer.
    Xu R; Hu J; Zhang T; Jiang C; Wang HY
    Oncotarget; 2016 May; 7(19):28579-91. PubMed ID: 27081037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Odd-skipped related 1 inhibits lung cancer proliferation and invasion by reducing Wnt signaling through the suppression of SOX9 and β-catenin.
    Wang Y; Lei L; Zheng YW; Zhang L; Li ZH; Shen HY; Jiang GY; Zhang XP; Wang EH; Xu HT
    Cancer Sci; 2018 Jun; 109(6):1799-1810. PubMed ID: 29660200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sox9 confers stemness properties in hepatocellular carcinoma through Frizzled-7 mediated Wnt/β-catenin signaling.
    Leung CO; Mak WN; Kai AK; Chan KS; Lee TK; Ng IO; Lo RC
    Oncotarget; 2016 May; 7(20):29371-86. PubMed ID: 27105493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SOX9 drives the epithelial-mesenchymal transition in non-small-cell lung cancer through the Wnt/β-catenin pathway.
    Huang JQ; Wei FK; Xu XL; Ye SX; Song JW; Ding PK; Zhu J; Li HF; Luo XP; Gong H; Su L; Yang L; Gong LY
    J Transl Med; 2019 May; 17(1):143. PubMed ID: 31060551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SOX9 and TCF transcription factors associate to mediate Wnt/β-catenin target gene activation in colorectal cancer.
    Ramakrishnan AB; Burby PE; Adiga K; Cadigan KM
    J Biol Chem; 2023 Jan; 299(1):102735. PubMed ID: 36423688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EZH2-mediated repression of GSK-3β and TP53 promotes Wnt/β-catenin signaling-dependent cell expansion in cervical carcinoma.
    Chen Q; Zheng PS; Yang WT
    Oncotarget; 2016 Jun; 7(24):36115-36129. PubMed ID: 27092879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repression of Wnt/β-catenin signaling by SOX9 and Mastermind-like transcriptional coactivator 2.
    Sinha A; Fan VB; Ramakrishnan AB; Engelhardt N; Kennell J; Cadigan KM
    Sci Adv; 2021 Feb; 7(8):. PubMed ID: 33597243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N6-Methyladenosine-Mediated Up-Regulation of FZD10 Regulates Liver Cancer Stem Cells' Properties and Lenvatinib Resistance Through WNT/β-Catenin and Hippo Signaling Pathways.
    Wang J; Yu H; Dong W; Zhang C; Hu M; Ma W; Jiang X; Li H; Yang P; Xiang D
    Gastroenterology; 2023 May; 164(6):990-1005. PubMed ID: 36764493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SOX9 regulates low density lipoprotein receptor-related protein 6 (LRP6) and T-cell factor 4 (TCF4) expression and Wnt/β-catenin activation in breast cancer.
    Wang H; He L; Ma F; Regan MM; Balk SP; Richardson AL; Yuan X
    J Biol Chem; 2013 Mar; 288(9):6478-87. PubMed ID: 23306204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SOX9/NFIA promotes human ovarian cancer metastasis through the Wnt/β-catenin signaling pathway.
    Lu R; Tang P; Zhang D; Lin S; Li H; Feng X; Sun M; Zhang H
    Pathol Res Pract; 2023 Aug; 248():154602. PubMed ID: 37315400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SOX9 regulated proliferation and apoptosis of human lung carcinoma cells by the Wnt/β-catenin signaling pathway.
    Guo YZ; Xie XL; Fu J; Xing GL
    Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4898-4907. PubMed ID: 30070325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of FAM83F by c-Myc promotes cervical cancer growth and aerobic glycolysis via Wnt/β-catenin signaling activation.
    Zhang C; Liu L; Li W; Li M; Zhang X; Zhang C; Yang H; Xie J; Pan W; Guo X; She P; Zhong L; Li T
    Cell Death Dis; 2023 Dec; 14(12):837. PubMed ID: 38104106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Claudin-7 deficiency promotes stemness properties in colorectal cancer through Sox9-mediated Wnt/β-catenin signalling.
    Xu C; Ding YH; Wang K; Hao M; Li H; Ding L
    J Transl Med; 2021 Jul; 19(1):311. PubMed ID: 34281572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA CASC11 promotes the cervical cancer progression by activating Wnt/beta-catenin signaling pathway.
    Hsu W; Liu L; Chen X; Zhang Y; Zhu W
    Biol Res; 2019 Jun; 52(1):33. PubMed ID: 31255182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AURKA governs self-renewal capacity in glioma-initiating cells via stabilization/activation of β-catenin/Wnt signaling.
    Xia Z; Wei P; Zhang H; Ding Z; Yang L; Huang Z; Zhang N
    Mol Cancer Res; 2013 Sep; 11(9):1101-11. PubMed ID: 23761169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA PVT1 contributes to cell growth and metastasis in non-small-cell lung cancer by regulating miR-361-3p/SOX9 axis and activating Wnt/β-catenin signaling pathway.
    Qi G; Li L
    Biomed Pharmacother; 2020 Jun; 126():110100. PubMed ID: 32197208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wnt signaling in ovarian development inhibits Sf1 activation of Sox9 via the Tesco enhancer.
    Bernard P; Ryan J; Sim H; Czech DP; Sinclair AH; Koopman P; Harley VR
    Endocrinology; 2012 Feb; 153(2):901-12. PubMed ID: 22128028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor activity of galaxamide involved in cell apoptosis and stemness by inhibiting Wnt/β-catenin pathway in cervical cancer.
    Yang G; He Y; Chen Y; Huang Z; Huang J; Ren X; Xu S; Li P
    Drug Dev Res; 2023 Sep; 84(6):1114-1126. PubMed ID: 37154105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.